an authorised publication of the european league against ......brussels. the new programme hori-zon...

• 2014 Congress Will Showcase Products ofCollaboration and Prospering Research

• Scientific Programme Has More AbstractsThan Ever Before, Especially From Asia

• Ultrasound Course Highlights BroadOffering in Health Professionals Sessions

• Practicalities of Living With RMDs Lie atthe Heart of the PARE Programme

• Young Clinicians, Health Professionals toFind Tailored Offerings at Congress

• Paediatric Sessions to Offer RelevantInsights Into Adult Disease

• Museums Contain a Wealth of History onParisian Medical Science

One interestingsession will involvelooking at the practical implications ofannual reviews inpatients with inflammatoryarthritis.

PROF. MAURIZIOCUTOLO

PROF. ULF MÜLLER-LADNER

PROF. CHRISTINA H.OPAVA

The EULAR Congress is an irreplaceable occasion to experience the latest advances inbasic, translational,and clinicalrheumatology.

The scientific programme’s hidden jewels arethe ‘basic immunology explained’ andbioenergetic sessions - rarelyprovided atrheumatologycongresses.

An authorised publication of the European League Against Rheumatism

eular Congress News

2014Preview Edition

2014 Congress Will Showcase Products ofCollaboration and Prospering Research

We are getting close to the startof the 15th Annual EuropeanCongress of Rheumatology

2014, and we look forward to welcomingyou to the wonderful city of Paris and theEULAR “family” for what is sure to be afulfilling and enriching educational expe-rience for all attendees.

EULAR now includes altogether morethan 100 active European scientific soci-eties, patient organisations, and healthprofessional associations from 45 Euro-pean countries. We are very pleased to seethe numbers of participants from theUnited States, Japan, Korea, and China,and also from South America, growingyear after year. Our continued collabora-tion with North America and the “EU-LAR Symposia” held at annual meetingsof AFLAR (African League of Associa-tions for Rheumatology), APLAR (AsiaPacific League of Associations forRheumatology), and PANLAR (PanAmerican League of Associations forRheumatology) are a result of the educa-tional experience and scientific collabora-tion at the annual EULAR meetings andoffer a stimulus to further expand supportto emerging countries and subcontinents.

Unquestionably, research in rheumaticand musculoskeletal diseases (RMDs) inEurope is prospering despite a rather ad-verse economic environment. It is there-fore with great satisfaction that we haveseen a progressive availability of EU re-search funds for RMDs in recent months,following several years of intensive discus-sion and negotiation by EULAR in the EUParliament and with the Commission inBrussels. The new programme HORI-ZON 2020 should open up research fundsfor RMDs. EULAR has also been the driv-ing force in creating a new Europeanfoundation with the aim of supporting re-search in rheumatology.

The 2014 Congress in Paris will featuremore than 4,000 submitted abstracts – anew record – from more than 90 coun-tries, and we are expecting at least 13,000registered participants from around theworld. I am convinced that a meetingsuch as the EULAR Congress is an irre-placeable occasion to immerge into thevast field of RMDs and to experience the

latest advances in basic, translational, andclinical rheumatology. New topics areemerging such as biosimilars, new sensi-tive biomarkers that help in very early di-agnosis of RMDs, or instruments such asjoint sonography or MRI, the extendedpresentation of new targeted therapies,and the optimisation of the use of low-dose, long-term glucocorticoids. Theseand many other excit-ing topics will be of-fered in over 180sessions by more than500 experts in over 650presentations. Ten ses-sions are dedicated tothe patient pillar(PARE) and 11 sessionsto the health profes-sionals pillar (HP) ofEULAR, which are in-dispensable carriers ofexchanges between allthe EULAR “familymembers.”

Important sessionsare dedicated to paedi-atric rheumatology and the youngrheumatologists who are more and moreinvited as speakers of abstracts to meetthe atmosphere of the great “platea.”The scientific programme again offersthe WIN and HOT session tracks focus-ing on aspects of novel developments inclinical science (WIN) and on best ap-proaches in the daily practice in our spe-cialties (HOT). The programme providescountless opportunities to hear about thelatest advances in rheumatology throughlectures, workshops, abstracts, poster pre-sentations, and symposia. The poster ar-eas will be accessible from early morning,and a large selection of Poster Tours willbe offered during poster sessions withhighest scientific content. Another suc-cessful initiative introduced last year is therecording of EULAR Congress sessions,which makes the majority of the sessionsavailable online to all registered partici-pants, and this year, to nonregistered par-ties, also.

The EULAR Village with the stands ofthe nonprofit organisations will offer am-ple opportunities to sit, meet, discuss, and

chat over a soft drink. The Opening Ple-nary Session on Wednesday, 11 June, willhost the Award Winner ceremoniesalongside short welcome addresses andother new elements. The Congress Din-ner on Friday, 13 June, held at the Liber-ty Pavillon Dauphine on the edge of Boisde Boulogne, will display an “atmosphèreparisienne.” As usual, EULAR 2014 offers

lunches to those spend-ing full days at theCongress and freetransportation on theParis city public trans-portation system. FreeInternet access has be-come a standard at EU-LAR Congresses bynow.

The city of Parisneeds little introduc-tion and will guaranteea fascinating location asit always has in thepast. Paris is an excel-lent city for an interna-tional meeting such as

the EULAR Congress thanks to the effi-cient connections and transportation op-tions. The “charme de la ville lumière”with its long history, reflected by its archi-tecture, galleries, restaurants, theatres,and music should provide an excellent at-mosphere for cultural exchange, interna-tional collaboration, and the renewal offriendships.

We look forward to having the honourand pleasure to welcome you – medicaldoctors, patients, health professionals,and representatives of the pharmaceuti-cal industry – to the 15th Annual EU-LAR Congress and hope your stay inParis will be enjoyable, informative, andeducational. ■

Prof. Maurizio CutoloPresident of EULARProfessor of Rheumatology and Internal MedicineDirector of Research Laboratory andAcademic Division of ClinicalRheumatologyDepartment of Internal Medicine,University of Genova, Italy

PROF. CUTOLO

2 15TH ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY

Scientific Programme Has More AbstractsThan Ever Before, Especially From Asia

This year’s EULAR Congress boastsa record-breaking number of ab-stracts submissions, particularly

because of rising participation from Asiancountries, as well as growing interest inosteoarthritis and management ofspondyloarthropathies. The overall qual-ity of research represented in the scientif-ic programme also has increased this year,according to Dr. Maya Buch,chair of the Abstract SelectionCommittee, and Prof. UlfMüller-Ladner, chair of theScientific Programme Com-mittee.

The increase in the numberof abstracts submitted “demon-strates EULAR’s continued po-sition as a leading WorldCongress that is attracting moreparticipation” each year, Dr.Buch said in an interview.

“The abstracts submitted cover an ex-cellent variety of themes and science thataddress clinically relevant issues and pro-vide insights into future opportunitiesand possibilities,” added Dr. Buch, who isSenior Lecturer and Honorary ConsultantRheumatologist at Chapel Allerton Hos-pital in Leeds, England. The EULAR Con-gress in Paris will thus be an informativeand inspiring meeting in a collaborativeand sociable setting, she observed.

Last year, a total of 3,870 abstracts weresubmitted, and the trend over the past fewyears has been for around 3,500-3,800 ab-stract submissions per year, but this yearsaw a further increase to 4,041 with an ac-ceptance rate of 85%. The split betweenbasic (14%) and clinical science abstracts(85%) remains broadly the same; as doesthe number of abstracts submitted bythe various scientific (3,812), Health Pro-fessionals in Rheumatology (185), andPARE (44) organisations.

While the majority of submitted ab-stracts were from the European Union(2,271), a large percentage came from oth-er countries in Asia (936), North America(445), Africa (218), South America (142),and Australasia (29). This is largely similarto previous congresses, with the exceptionof more abstracts submitted by Asia-basedresearchers. “This seems to be due to in-

creasing interest of our Japanese colleagues– with Japan now being the top-submittingcountry (with the United States second,and Spain third),” Dr. Buch said.

The increase in submissions is acrossall the main disease areas and topics, butthe largest increase has been seen in ab-stracts relating to osteoarthritis and theclinical management of spondy-

l o a r t h r o p a t h i e s(SpA). There willbe an oral abstractsession on the clin-ical aspects of os-teoarthritis that islikely to garner alot of interest, Dr.Buch said, as this isa disease area thatconstitutes a con-siderable health

burden and is being encoun-tered with increasing frequency inrheumatologic practice.

There will be three oral sessions in thearea of systemic lupus erythematosusand Sjögren’s syndrome covering clinical,treatment-focused, and basic/transla-tional aspects, she said, reflecting in-creased opportunity in this field andassociated research activity. “We alsohave good [representation] in scleroder-ma with a clinical and basic [science ab-stract] session. The pathogenesis ofrheumatoid arthritis (particularly ACPA-related biology) and comorbidities inRA, particularly cardiovascular, continueto be areas of interest,” Dr. Buch said.

“Getting to the heart of CTDs [connec-tive tissue diseases]” is also likely to be oneof the highlights of the abstract-basedprogramme and will look at primary car-diovascular manifestations in patientswith CTDs. Although more subspecialist,this is an area of morbidity and mortali-ty with poor understanding that has beenrelatively less researched, according toDr. Buch. Other highlights are likely to in-clude the abstract sessions on emergingconcepts in genomics and genetics, whichaddress the goal of personalised medicineand explore the potential use of gene ex-pression profiles as well as non–TNF bi-ologics and small molecules in RA.

Prof. Müller-Ladner, who is Professor ofInternal Medicine and Rheumatology atthe Justus–Liebig University Giessen andDirector of the Department of Rheuma-tology and Clinical Immunology at Ker-ckhoff-Klinik, Bad Nauheim, Germany,noted that it is not just the number of ab-stracts that has increased, but also theoverall quality of research. He suggested

several areas of the scientificprogramme that should not bemissed.

“The ‘basic immunology ex-plained’ sessions are the hiddenjewels,” he said. “Everybody istalking about immunologicaldisease and immunomodifyingdrugs, but the true understand-ing [of] what is behind thescenes is rarely provided atrheumatology congresses.”

Another hidden jewel will bethe bioenergetics session, which is a noveland unique topic. Speakers at the sessionwill look at energy metabolism and rheu-matic diseases, the immune system as asensor of the metabolic state, and themammalian target of rapamycin (mTOR)as an important regulator of macrophagedifferentiation and function.

One of the podium sessions will addressfuture hot topics and “the challenges of to-morrow addressed today.” Outstandingspeakers will visualize the future, address-ing the role of genetics, fibroblasts, the Ep-stein-Barr virus, and glucocorticoids inthe development and management ofrheumatic and musculoskeletal diseases.

There will be a session on biosimilarsthat will also be important because biosim-ilars are going to be the big challengers toestablished biologic therapies, especially ifthey are sold at two-thirds to half the costin some countries. “There is intensive dis-cussion as to whether they are really ‘equiv-alent’ for all diseases,” Prof. Müller-Ladnersaid, noting that biosimilars have been as-sociated with equivalent efficacy as com-pared with the originator biologics, butsometimes high rates of immunogenicityhave been observed in the current trials.

New developments in myositides is an-other highlight of the scientific pro-

DR. BUCH PROF. MÜLLER-LADNER

Continued on following page

2014 EULAR CONGRESS NEWS PREVIEW EDITION 3

Ultrasound Course Highlights BroadOffering in Health Professionals Sessions

The Health Professionals inRheumatology Sessions will offerdelegates with a broad interest in

the health and well-being ofpeople with rheumatic andmusculoskeletal diseases(RMDs) the opportunity tohear some of the latest re-search and obtain useful clini-cal pointers that they can applyto their daily practise.

Prof. Christina H. Opava,who is the EULAR Vice-Presi-dent representing Health Pro-fessionals in Rheumatology(HPRs), noted in an interview that HPRsare important members of the multidis-ciplinary team that treats people withRMDs, and it is vital that they use meth-ods and interventions that are evidencebased, effective, and efficient. “It is impor-tant for HPRs to share research results andclinical experience, to network and togain new knowledge to integrate into fu-ture research activities or daily clinicalpractise,” she observed.

This year the programme for HPRswill consist of 12 podium sessions andtwo poster tours covering a variety of top-ics, such as identifying threats to health,diagnosing poor functioning and health,and evaluating nonpharmacological inter-ventions and different forms of care deliv-ery. Presentations will also look at theimplementation of novel treatments intothe regular care of people with RMDs.

The programme starts on Wednesday,

11 June, at 13:30-14:30, with a general wel-come for all the HPR attendees. This willbe followed at 15:00-16:30 by what is like-

ly to be one of the highlightsof the programme – a sessionon the use of ultrasound imag-ing. “The use of ultrasound isnew to HPRs, and we expectthe session on how to imple-ment it into clinical practisewill be well attended,” ex-plained Prof. Opava, who isprofessor of physiotherapy atthe Karolinska Institutet inStockholm.

Other interesting sessions include onelooking at the practical implications of an-nual reviews in patients with inflammato-ry arthritis, being held Friday, 13 June,15:30-17:00. “In many countries, there isa wish to reduce the time that patients getaccess to the team,” Prof. Opava said, not-ing that “this work shows what value canbe added with a strong evidence base andworking not just in our disease area butimproving overall health and well beingoutcomes.”

Prof. Opava will moderate a session onWednesday at 17:00-18:30 that will look athow well health care professionals aredoing at promoting a healthy lifestyleamong their patients with arthritis. Thisincludes looking at ways to encouragebetter cardiovascular health and to man-age other risks to health via nonpharma-cologic methods such as smokingcessation and exercise. This is particular-

ly important as smoking and physical in-activity may predict a poorer diseasecourse, less benefit from medication, andpotentially more disability among peoplewith RMDs.

There will be two abstract sessions held10:15-11:45 on both Thursday and Fridaythat will provide a platform for re-searchers to share their findings with thehealth professional community and oth-er interested delegates attending the EU-LAR Congress. “We are particularlyexcited about the content of abstracts se-lected for the Health Professionals inRheumatology awards and hope that con-gress delegates will take the opportunityto listen to those presentations withinthe HPR abstract sessions,” Prof. Opavasaid.

There is one joint clinical session on pa-tient education for people with inflamma-tory rheumatic disease that will be held inassociation with People with Arthritis andRheumatism in Europe (PARE). This willbe held on Saturday, 14 June, 12:00-13:30.There will also be a session on Thursday,15:30-17:00, looking at eHealth literacy onthe rheumatic diseases and how the Inter-net influences peoples’ knowledge of theirdisease.

The programme ends with a highlightssession on Saturday 13:45-14:45, which isdesigned to inform HPRs about otherimportant sessions at the EULAR Con-gress, including those included in themain scientific programme and the PAREsessions. ■

PROF. OPAVA

gramme, with three experts lined up todiscuss the development of new classifi-cation criteria, the role of imaging tech-niques in early vs. late-presenting disease,and the management of interstitial lungdisease in myositis.

A high number of systemic sclerosis(SSc) abstracts have been accepted for pres-entation at this year’s Congress and data onseveral new animal models or treatmentsare likely to be of great interest. Data onmacitentan in SSc will be presented, for ex-ample, which is currently licensed as an or-

phan drug for pulmonary arterial hyperten-sion (PAH), including PAH associated withconnective tissue disease. There will also benew data released from the Very Early Di-agnosis of Systemic Sclerosis (VEDOSS)EUSTAR (EULAR Scleroderma Trials andResearch Group) multicentre study.

Other new data on the use of ustek-inumab for psoriatic arthritis will be pre-sented during the scientific programmeand likely to be popular among delegates,as will sessions on axial SpA and im-munoglobulin G4–related diseases.

Delegates should also consider attend-ing some of the PARE (People with

Arthritis and Rheumatism in Europe) andHealth Professionals in Rheumatology(HPR) sessions.

“The interaction with patients is crucialfor physicians and researchers to commu-nicate ideas and needs back and forth andnot to lose track of the treatment needsof patients,” Prof. Müller-Ladner said.

Similarly, the HPR programme is im-portant as it bridges the gap betweenphysicians and patients. HPRs have com-pletely different roles in different coun-tries, he observed, so it is good for theserheumatology professionals to have theplatform to share their experiences. ■

Continued from previous page


EULAR 2014 Satellite Symposia

Looking Beyond Uric Acid and Gout: Crystallizing the Science

Uric Acid, Crystal Deposition Disease, and Gout

Uric Acid and the Future of Gout Management

Chair: N. Lawrence Edwards, USA; Alexander So, Switzerland; Jeffrey Miner, USA

Chair: Thomas Bardin, France; Nicola Dalbeth, New Zealand; Fernando Perez-Ruiz, Spain

Wednesday, 11 June 2014, 13.00–14.30 Room 242 AB, Le Palais des Congrès de Paris, Paris, France

Friday, 13 June 2014, 08.15–09.45Room 351, Le Palais des Congrès de Paris, Paris, France

EULAR 2014 Satellite Symposium funded and organized by

Practicalities of Living With RMDs LieAt the Heart of the PARE Programme

The People with Arthritis andRheumatism in Europe (PARE)programme will deal with some of

the most important issues faced by peo-ple with rheumatic and musculoskeletaldiseases (RMDs) in Europe. One of thekey sessions will discuss howsuccessful advocacy canchange the lives of people liv-ing with RMDs.

“Political campaigning is acore activity of PARE,” MariosKouloumas, the EULAR Vice-President representing PAREand president of the CyprusLeague Against Rheumatism,said in an interview. “Our roleis to raise the awareness andalso to inform the politicians and the pol-icy makers about the problems that weface and push for the measures that theyshould take in order to improve the qual-ity of life of people with rheumatic dis-eases,” he observed.

During the session on political cam-paigning, which will be held on Wednes-day, 11 June, 17:00-18:30, attendees willhave the opportunity to hear Neil Bet-teridge, EULAR International Liaison Of-ficer, Public Affairs, present the newEULAR strategy for patient advocacy inEurope. Annelisa Cotone from the Euro-pean Commission in Brussels will talkabout the implementation of the UnitedNations convention on disability rightsand the EU Disability Strategy 2010-2020,and Anne Carlsson, president of theSwedish Rheumatism Association, willpresent a political strategy to enable peo-ple with RMDs and other chronic illness-es to stay in work.

A critical component of advocacy is en-suring that access to treatment and serv-ices is provided in all countries and thatthey are of high quality. A session onThursday, 12 June, 13:30-15:00, will lookat how the economic crisis in Europe hasaffected health service availability and de-livery for RMDs and how the obstaclesfaced nationally could be turned into op-portunities. Economic austerity can oftenlead to innovative solutions for the deliv-ery of health care and patient self-man-agement, as well as instigate major

changes in how organisations work.The PARE programme starts on

Wednesday, 13:30-14:30, with a welcomesession for all PARE delegates. This is in-tended to introduce attendees to the facil-ities available within the Congress centre

and venues in which the PAREsessions will take place. Thewelcome session will also pro-vide attendees with anoverview of the main topicsthat will be discussed over the 4days of the PARE programme.

The first of 11 podium ses-sions held on Wednesday,15:00-16:30, will look at the roleof diet in RMDs and makinghealthy choices. Nutrition ex-

pert Henriette Thorseng of the DanishRheumatism Association will look at therole of food as therapy and psychologistVasiliki Cristodoulou from Cyprus will ex-amine barriers to putting knowledgeabout healthy eating practices and dietinto practice. Also in the session, EULARPresident, Prof. Maurizio Cutolo, from theUniversity of Genova in Italy, will discussthe role of vitamin D.

The quality of the presentations and ab-stracts submitted this year is very high, ac-cording to Mr. Kouloumas. The abstracts,which will be presented throughout theprogramme and, in one dedicated session,will cover the activities of the various na-tional PARE organisations. For the firsttime at the Congress, there will be aPARE Best Abstract award, which will bepresented at the Opening Plenary Sessionon Wednesday. In addition, a very impor-tant and new activity during this year’sCongress will be the poster tours organ-ised by the Standing Committee of PARE.Although there was an unofficial PAREposter tour at EULAR 2013 in Madrid,there will be two official poster tours thisyear on Thursday and Friday.

The first podium session on Thursday,10:15-11:45, will look at the role of newtechnologies in improving and facilitatingthe way in which people with RMDs andtheir health care teams can interact. Thiswill include talks on the latest innovationsin telemedicine, personalised medicine,and self-management, and how technol-

ogy can aid communication between doc-tors and their patients. Also to be held onThursday, 15:30-17:00, is the established“Latest advances in the treatment andmanagement of RMDs” session. Thisyear, the presentations will focus onbiosimilars and orphan drugs.

Two of Friday’s podium sessions willlook at topics on aging and RMDs. Thefirst, at 13:30-15:00, will highlight thecomplexities of growing up with an RMDand the importance of the role of parents,guardians, and the health care team in thisprocess. The second, at 15:30-17:00, willlook at growing older with an RMD. Top-ics that will be covered in the latter sessioninclude the presence and management ofcomorbidities in older people with RMDs;how older individuals have been support-ed by national PARE initiatives; physio-therapy to help people remain as active aspossible as they age; and the effects thatRMDs may have on the ability to contin-ue working, with discussion of how toovercome the challenges that may befaced.

Sessions on Saturday, 14 June, look atthe practicalities of traveling with anRMD (8:30-10:00), and the importance ofpeer support in chronic diseases (12:00-13:30). In theses two sessions, delegateswill learn how people with RMDs haveovercome practical difficulties and seizednew opportunities to travel and how net-working and self-help strategies have ledorganisations to achieve success in theface of strong competition for influenceand scarce resources, respectively.

“EULAR is a very big Congress withmany important sessions,” Mr. Kouloumasobserved. As it is not possible for PARE del-egates to attend all of the sessions thatmight be of interest or importance, thePARE programme will end with a generalhighlights session on Saturday, 13:45-14:45.During the hour-long session, MichaelaStoffer of the Medical University of Vien-na, Austria, will present highlights of theHealth Professionals in Rheumatology pro-gramme and Dr. Loreto Carmona, arheumatologist and scientific director ofthe Institute for Musculoskeletal Health,Madrid, will provide highlights from themain scientific programme. ■

MR. KOULOUMAS


Roche-sponsored satellite symposium at EULAR 2014

Joint decisions: Personalising RA therapy to achieve better outcomes

Based on US rules, this symposium is only intended for physicians practicing outside the USA

FacultyProf. Ernest Choy, UK (co-Chair) Prof. Andrea Rubbert-Roth, Germany (co-Chair) Dr Cécile Gaujoux-Viala, France Dr Andrew Östör, UK

Thursday 12 June 2014 | 08:15–09:45 | Grand Amphi | Le Palais des Congrès de Paris

Young Clinicians, Health ProfessionalsTo Find Tailored Offerings at Congress

Young rheumatologists and re-searchers at EULAR 2014 will dis-cover an especially strong track

designed just for them – both as part ofthe official scientific programme and inthe form of extra-congressional activitiesaimed at promoting networking, mentor-ing, and education.

At the heart of the young rheumatolo-gists’ scientific track this year are sessionson epidemiology and immunology. Theseare aimed specifically at nonexperts, willhave an informal tone, and are being ledby exceptional educators, said Dr. PedroMachado, the 2013-2014 chair of theEmerging EULAR Network, or EME-UNET, the working group started in 2010for young clinicians and researchers inrheumatology.

The epidemiology and immunologysessions will help young rheumatologiststo get a handle on the basics of these dis-ciplines in order to apply them in re-search settings, “or even just to be betterat reading articlesand interpretingthem,” Dr. Macha-do said in an inter-view.

And for the 4thyear in a row at EU-LAR, the track willhave been created inpart using feedbackand survey respons-es from young rheumatologists.

“We have tried to make this track bet-ter by tailoring it to young rheumatolo-gists’ and researchers’ expectations,” saidDr. Machado, a rheumatologist and sen-ior clinical research associate at Universi-ty College London. “Some of the topicsthat will be covered were actually suggest-ed by young people” through EMEUNETsurveys.

The 2014 scientific programme will in-clude tailored seminars on career develop-ment, research trends, funding research,and e-health – online monitoring of pa-tient-reported outcomes and medical appsin daily practise, quality of care, and tele-monitoring. Fellows who have receivedEULAR educational grants will presentthe results of their fellowship during two

dedicated sessions at the Congress, and allof the scientific programme offerings foryoung rheumatologists will be scheduledfor the same session room, making themeasy to locate, Dr. Machado said.

Also during theCongress, membersof the EULARStanding Commit-tee on Educationand Training (ES-CET) will presentand explain EU-LAR’s educationalportfolio, includingits online courses.One speaker willdetail the EULAR course in ultrasoundtraining, “an important topic to youngrheumatologists,” Dr. Machado said.

Susan Oliver, the EULAR StandingCommittee Chair for Health Profession-als in Rheumatology, described offeringsfor health professionals that complement

several of those onthe young rheuma-tologists’ track andare intended to lendthemselves to “across-pollination” ofideas. “One of thereally interestingthemes is howyoung rheumatolo-gists understand

new models of care and how we work to-gether toward sustainable healthcare for2020 and beyond. We are thinking a bitmore as to how that might fit together,particularly within the clinical practise,”said Ms. Oliver, an independent nurseconsultant in rheumatology, North De-von, England.

In the Congress sessions for healthprofessionals, “We have some very inter-esting themes this year – looking at howwe might collaborate and learn from theresearch process, for example, in areassuch as nonpharmacologic research andrare diseases,” Ms. Oliver said in an inter-view.

The health care professionals trackfeatures a session toward the end of theCongress to present highlights of the

health care professionals programme –including from a rheumatologist’s per-spective. Health care professionals willalso find sessions on e-health and on ul-trasound, “which has become impor-

tant to health careprofessionals aswell as youngrheumatologists,”Ms. Oliver said.

Young healthprofessionals willfind, for the secondyear at the Con-gress, study groupsthat focus on “pro-viding a forum for

health professionals to discuss specific ar-eas for future research or consider waysto improve implementation of currentevidence. It is a great opportunity tonetwork and plan collaboratively,” Ms.Oliver said, adding that the workshopsoccur outside the formal Congress ses-sions.

Health professionals will also have adedicated stand in the EULAR Village,which Ms. Oliver called “a resource for thelatest Congress and newsletter informa-tion, as well as an opportunity to meetmembers of the committee, country pres-idents, and those interested in being moreactively involved in EULAR activities.”

The young rheumatologists’ groupEMEUNET will also be hosting inde-pendent social and educational eventsdesigned to augment – but not competewith – the official EULAR programme.These are scheduled for early mornings,evenings, and lunch times, outside regu-lar session hours. The offerings include asightseeing tour of Paris for youngrheumatologists, with the goal of en-couraging social and professional net-working.

Another key EMEUNET initiative willbe mentoring meetings in which selectedexperts “get together with two or threeyoung fellows each, in order to discuss ca-reer planning, career aspirations, and re-search,” Dr. Machado said. “This willallow them to get some advice from old-er and more experienced rheumatolo-gists from a mentorship perspective.” ■

DR. MACHADO MS. OLIVER

The programme will includeseminars on career development,research trends and funding, as

well as online monitoring ofpatient-reported outcomes andmedical apps in daily practise.


New Horizons,New Possibilities:ADVANCES IN THE MANAGEMENT OF AXIAL SPONDYLOARTHRITIS

DRUG SURVIVAL ON BIOLOGIC THERAPYThe Secrets of

Success:

The Transformation of RheumatoidArthritis Treatment:THE ROLE OF EMERGING THERAPIES INTHE MODERN TREATMENT PARADIGM

Wednesday, 11 June 201413:00 - 14:30

Le Palais des Congrès de ParisTernes Room

Thursday, 12 June 2014

08:15 - 09:45

Le Palais des Congrès de Paris

Ternes Room

Thursday, 12 June 201417:30 - 19:00

Le Palais des Congrès de ParisTernes Room

A program funded and sponsored by Pfizer Inc. All rights reserved.



Dat

e o

f p

rep

arat

ion

: Mar

ch 2

014

E

U-J

AK

-42-

03

2014

Programs funded and sponsored by Pfizer Inc. All rights reserved.

THE EUROPEAN LEAGUE AGAINST RHEUMATISM [EULAR] 2014 | 11-14 JUNE 2014 | PARIS | FRANCE

Join Us! Add These Symposia

Stops to Your EULAR tinerary

Paediatric Sessions to Offer RelevantInsights Into Adult Disease

Innate immunity and sterile inflamma-tion are at the centre of the paediatrictrack at EULAR 2014 – a track that has

much to offer the adult rheumatologist aswell.

This EULAR Congress “is really linkedbetween adults and children,” said Prof.Johannes Roth of the University Hospitalof Münster in Germany. Prof. Roth, pastchair of EULAR’s Standing Committeeon Paediatric Rheumatology, is helpingdesign the pediatric scientific programalong with current chair Prof. AlbertoMartini of the University of Genova, Italy.

“Paediatricians treat some inborn in-flammatory disorders that arise from de-fects in the innate immune system –autoinflammatory diseases,” said Prof.Roth. “And the same mechanisms alsoplay an increasingly recognised role inadult rheumatology.” Sterile inflamma-tion, seen both in adults and children, willbe discussed both as part of the adultrheumatology track and the pediatrictrack, and Prof. Roth advises interested cli-nicians to seek out talks from both.

Paediatric rheumatologists’ knowledgeof inborn inflammatory diseases has pro-vided them an intimate understanding ofinnate immunity and sterile inflamma-tion. “These are two of the few areas ofrheumatology in which we paediatricianshave a little bit more experience, and inwhich adult practitioners can learn from

us,” Prof. Roth said. “Usually, it’s the oth-er way around – every time there’s a newtarget or new drug, it’s tried in adults forsafety reasons; 5-10 years later, it comes tous, and we have to primarily rely on theexperience of adult clinicians to guide usas to how to use in it children.”

Autoinflammatory disorders, by con-trast, “come from rare inborn errors pre-senting during childhood from which wehave learned so much about inflammato-ry diseases, and all of this is relevant for theadult clinician. Therefore, the paediatricsessions may be interesting to a broadergroup of people coming to the congress.”

Highlights for paediatric rheumatolo-gists off the main paediatric track includeHOT, or “How to Treat” sessions, whichwill also feature some paediatric presen-ters and take up some paediatric topics.Additionally, EULAR’s Standing Commit-tee on Paediatric Rheumatology will be

discussing networks, grants, and interna-tional studies within EULAR.

The main paediatric track fills onlyabout half to two-thirds of the congresstime slots, all in a dedicated room. Theprogram is already fixed but has someroom left for late-breaking abstracts.

The space in the program, Prof. Rothsaid, provides paediatric clinicians ampleopportunity to select the adult rheumatol-ogy sessions they find most valuable. Be-cause the European paediatric rheum-atology community is small and close knit,with its own specialized congresses, hesaid, EULAR offers paediatric rheumatol-ogists the opportunity to attend sessions –whether basic research or clinical practice– to learn about diseases that they know,but in which adult rheumatologists see 10-100 times more patients.

This year, as with last year, the paedi-atric committee will highlight a couple ofadult disease sessions of particular rele-vance to paediatric practitioners. But forthe most part, paediatric rheumatologistscan use their own discretion in choosingwhich adult congress sessions to attend.

For example, very specialised paedi-atric rheumatologists might see only veryfew patients with scleroderma, so “itcould be interesting to go to a session inwhich an adult specialist offers anoverview on treating scleroderma pa-tients,” Prof. Roth said. ■

PROF. ROTH PROF. MARTINI

EULAR PresidentProf. Maurizio Cutolo, ItalyEULAR President-ElectProf. Gerd Rüdiger Burmester, GermanyChair, Scientific Programme CommitteeProf. Ulf Müller-Ladner, GermanyChair, Abstract Selection CommitteeDr. Maya Buch, United Kingdom

Frontline Medical NewsPUBLICATION STAFFEditor Jeff EvansDesigner Yenling LiuProduction Manager Rebecca SlebodnikAdvertising Director Aaron Wattenberg+001 973 290 8212Director/FMC Society Partners Mark Branca+001 973 290 8246

©Copyright 2014European League Against RheumatismEULAR Executive SecretariatSeestrasse 240, CH-8802Kilchberg, Switzerland Tel: +41 44 716 30 30Direct line: +41 44 716 30 31Fax: +41 44 716 30 39E-mail: [email protected]

Produced and distributed for EULAR by FrontlineMedical News, a division of Frontline MedicalCommunications, Inc. All rights reserved. No partof this publication may be reproduced ortransmitted in any form, by any means, withoutprior written permission of EULAR. The opinionsexpressed in this publication are those of thepresenters and authors and do not necessarilyreflect the views of EULAR.

eular Congress News

2014 Preview EditionAn authorised publication ofthe European League AgainstRheumatism


Paris has been one of the world’sgreat cultural centres since the lateMiddle Ages and was part of the

flowering of the early Renaissance whenthe University of Paris was founded in the12th century – with medicine as one of itsearliest courses of instruction.

Visitors to Paris can sample this fasci-nating history of medicine as it is dis-played in a number of unique museumslocated throughout the city’s environs.Below are five of those museums, inparticular, which are of note for thosewho have an interest in both the historyand culture of medicine throughout theages.

These museums feature preserved ar-tifacts of living specimens, medical in-strumentation, artistic reproductions ofdisease states, and the memorabilia of ahost of great French physicians, includ-ing the incomparable Louis Pasteur. To-gether, their collections catalogue thesweep of Parisian medicine across thecenturies.

Museum of the History of Medicine(Le Musée d’Histoire de la Médecine)Housed in a great hall constructed in1905, the museum is located at the sec-ond floor of the Paris V René DescartesUniversity in the homeof the university’s his-toric Faculty of Medi-cine. The collectionswere begun in the 18thcentury and today con-tain a renowned as-semblage of surgicaland diagnostic instru-mentation, as well aspaintings, engravings,and lithographs rele-vant to several areas ofmedicine.

Orfila Museum ofAnatomy (Le Muséed’Anatomie Delmas-Orfila-RouviéreThe museum, in exis-tence since 1847, focus-es on anatomy with avariety of collections

of human and animal anatomical prepa-rations, embryological reconstructions,as well as neurological and anthropolog-ical specimens. Since 1953, the museumhas been housed as a series of show-rooms and galleries on the eighth floor ofthe Faculty of Medicine in the Rue desSaints-Peres rooms of the Paris V RenéDescartes University. The official website

contains a virtual tour of this fascinatingmuseum, and many of its artifacts are asmuch works of art as scientific displays.The museum is open on Tuesdays andThursdays only, 14:00-17:00, by prior ap-pointment, which you must arrange bytelephone well in advance.

Dupuytren Museum (Le MuséeDupuytren)Founded in 1835, this remarkable muse-um, located in the Université Pierre &Marie Curie, contains a wealth of histor-ical artifacts related to anatomicalpathologies. Skeletons, wax castings, anda large collection of jars containing pre-served organs and fetuses illustrate themedical and cultural obsession with“monstrosities” in an earlier era.

Museum of the Hospital of Saint Louis(Le Musée de l’Hôpital Saint-Louis)This museum is most known for its vastdermatologic collection – watercolorsand wax casts depicting a host of skin dis-eases, many of which have been on dis-play since the museum’s opening in 1867.There are more than 4,800 casts of skindiseases, with a strong concentration onthe various manifestations of syphilis,and all of the remarkable casts are visibleLe Musée de l’Hôpital Saint-Louis displays more than

4,800 casts of skin diseases.

CO

UR

TE

SY

HE

NR

YS

AL

OM

É,

WIK

IME

DIA

CO

MM

ON

S


Museums Contain a Wealth of HistoryOn Parisian Medical Science

Le Musée d’Histoire de la Médecine contains many surgical and diagnostic instruments.

CO

UR

TE

SY

LU

CA

BO

RG

HI,

WIK

IME

DIA

CO

MM

ON

S

Continued on page 13

Will doing this activity be challenging for your digital ulcer patients?

Date of preparation: May 2014 14005511_EULAR_ADVERT_05.2014


Come to Stand M27Aand let’s talk

Date of preparation: May 2014 14005511_EULAR_ADVERT_05.2014

in the online collection. Portions of thehospital itself exist as an architecturalmuseum, with examples of the originalbuildings surviving from its founding inthe 17th century.

Pasteur Museum (Le Musée Pasteur)The great Louis Pasteur (1822-1895) isrepresented in his own musée, locatedwithin the Institut Pasteur, which hefounded, at 25 Rue du Docteur Roux,Paris, France.

The museum preserves the apartment

where Pasteur spent the last 7 years of hislife, as well as the Neo-Byzantine-stylechapel in which he is buried. There is alsoan exhibit room containing around 1,000scientific instruments on display. The mu-seum also houses a huge collection of his-torical documents and images. ■

WIK

IME

DIA

CO

MM

ON

S

Le Musée Pasteur houses around 1,000 scientific instruments.

CO

UR

TE

SY

LU

CA

BO

RG

HI,

WIK

IME

DIA

CO

MM

ON

S

Louis Pasteur’s tomb at Le Musée Pasteur.

Continued from page 11

Scientific Secr

an authorised publication of the european league against ......brussels. the new programme hori-zon...

Documents